Pomalidomide (Pomalyst) in combination with bortezomib and dexamethasone (PVd) will be reimbursed on the PBS from 1 October for patients with...
Day: 13 October 2021
ATAGI specifies which patients with haematological malignancy should have COVID-19 booster vax
People with blood cancers who are immunocompromised are now advised to have a third primary dose of COVID-19 vaccine with an mRNA vaccine. On 8...